Skip to main content
    R

    Revvity Inc. (RVTY)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE

    $155.08
    -0.53 (-0.34%)

    Market Cap: $16.97B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    90%(35/39)
    Avg Surprise
    +9.71%
    Streak
    11 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$1.30
    Range$1.28 - $1.33
    16 analysts
    EPS RevisionsNo revisions (7d)
    0
    12
    30d
    EPS Estimate DriftChange to current
    90d ago$1.31-1.2%
    60d ago$1.29+0.6%
    30d ago$1.29+0.3%
    7d ago$1.29+0.3%
    Current$1.30
    Revenue Consensus
    $695M
    Range$691M - $703M
    15 analysts
    Period ending Dec 31, 2026
    EPS Consensus$1.82
    Range$1.79 - $1.87
    17 analysts
    Revenue Consensus
    $751M
    Range$743M - $764M
    16 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$1.82---
    Sep 26EST
    		-$1.30---
    Jun 26
    Reported Jul 27
    		$1.41$1.23+14.63%Beat+19.5%
    Mar 26
    Reported May 5
    		$1.06$1.01+4.95%Beat+5.0%
    Dec 25
    Reported Feb 2
    		$1.70$1.58+7.59%Beat+19.7%
    Sep 25
    Reported Oct 27
    		$1.18$1.14+3.51%Beat-7.8%
    Jun 25
    Reported Jul 28
    		$1.18$1.14+3.51%Beat-3.3%
    Mar 25
    Reported Apr 28
    		$1.01$0.95+6.32%Beat+3.1%
    Dec 24
    Reported Jan 31
    		$1.42$1.38+2.90%Beat+13.6%
    Sep 24
    Reported Nov 4
    		$1.28$1.13+13.27%Beat+8.5%
    Jun 24
    Reported Jul 29
    		$1.22$1.12+8.93%Beat+0.8%
    Mar 24
    Reported Apr 29
    		$0.98$0.94+4.26%Beat-3.0%
    Dec 23
    Reported Feb 1
    		$1.25$1.16+7.76%Beat-26.5%
    Sep 23
    Reported Oct 30
    		$1.18$1.19-0.84%Miss-21.9%
    Jun 23
    Reported Aug 1
    		$1.21$1.19+1.68%Beat-47.8%
    Mar 23
    Reported May 11
    		$1.01$1.02-0.98%Miss-58.1%
    Dec 22
    Reported Feb 14
    		$1.70$1.66+2.41%Beat-33.6%
    Sep 22
    Reported Nov 8
    		$1.51$1.48+2.03%Beat-34.6%
    Jun 22
    Reported Aug 1
    		$2.32$2.01+15.42%Beat-18.0%
    Mar 22
    Reported May 3
    		$2.41$2.12+13.68%Beat-35.2%
    Dec 21
    Reported Feb 1
    		$2.56$2.35+8.94%Beat-35.4%
    Sep 21
    Reported Nov 2
    		$2.31$1.92+20.31%Beat+10.5%
    Jun 21
    Reported Jul 26
    		$2.83$2.44+15.98%Beat+80.3%
    Mar 21
    Reported May 4
    		$3.72$3.07+21.17%Beat+455.2%
    Dec 20
    Reported Feb 2
    		$3.96$3.02+31.13%Beat+193.3%
    Sep 20
    Reported Oct 28
    		$2.09$1.49+40.27%Beat+97.2%
    Jun 20
    Reported Jul 28
    		$1.57$0.88+78.41%Beat+57.0%
    Mar 20
    Reported May 5
    		$0.67$0.52+28.85%Beat-2.9%
    Dec 19
    Reported Jan 27
    		$1.35$1.33+1.50%Beat+14.4%
    Sep 19
    Reported Oct 30
    		$1.06$1.01+4.95%Beat+17.8%
    Jun 19
    Reported Jul 29
    		$1.00$1.00+0.00%Beat+9.9%
    Mar 19
    Reported Apr 25
    		$0.69$0.66+4.55%Beat+9.5%
    Dec 18
    Reported Mar 31
    		$1.18$1.16+1.72%Beat+21.6%
    Sep 18
    Reported Oct 31
    		$0.90$0.92-2.17%Miss+23.3%
    Jun 18
    Reported Aug 1
    		$0.91$0.86+5.81%Beat+35.8%
    Mar 18
    Reported Apr 30
    		$0.63$0.61+3.28%Beat+14.5%
    Dec 17
    Reported Mar 31
    		$0.97$0.94+3.19%Beat+16.9%
    Sep 17
    Reported Nov 2
    		$0.73$0.72+1.39%Beat-
    Jun 17
    Reported Aug 3
    		$0.67$0.67+0.00%Beat-
    Mar 17
    Reported May 4
    		$0.55$0.54+1.85%Beat-
    Dec 16
    Reported Mar 31
    		$0.83$0.86-3.49%Miss-

    Dividends

    Dividend Metrics

    Forward Yield0.18%
    Forward Annual Dividend$0.28
    Payout Ratio4.98%
    FrequencyQuarterly
    Pay MonthsFeb, May, Aug, Nov

    Growth

    3Y CAGR+0.00%
    5Y CAGR+0.00%
    RVTY dividend history and ex-dividend datesRun RVTY in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio28.99EV/EBITDA25.12x
    Price/FCF31.01xFCF Yield3.23%
    Profitability
    Profit Margin8.16%Operating Margin17.10%
    ROE3.21%ROIC3.13%
    Financial Health
    Debt/Equity0.44xInterest Coverage3.66x
    Current Ratio1.80xQuick Ratio1.50x
    Trading Statistics
    Beta1.06Avg Volume2.26M
    52-Week High$166.2552-Week Low$81.17

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$153.48
    SMA 20$150.26
    SMA 50$133.75
    SMA 200$108.21
    EMA 10$152.98
    EMA 20$148.65
    EMA 50$136.79
    EMA 200$113.85

    MACD

    Line: 6.28Signal: 6.78Hist: -0.50

    ADX

    ADX: 42.6+DI: 36.4-DI: 13.0

    Aroon & PSAR

    Aroon Up80.0
    Aroon Down8.0
    PSAR$165.10

    Bollinger Bands

    Upper Band$159.42
    Lower Band$141.11
    %B Position1218%(Upper)
    Band Width0.76

    RSI (14-Day)

    Neutral
    66.1

    Momentum Oscillators

    Stoch %K55.9
    Stoch %D53.2
    Williams %R-45.7
    ROC (10d)1.5%
    Momentum2.31
    CCI (20d)91.6
    MFI (14d)77.6

    Volatility Measures

    ATR (14d)$5.44(3.5%)
    StdDev (20d)4.58
    Hist Vol34.2%(Moderate)

    Volume Flow

    VWAP$155.21
    OBV30.6M
    AD Line1.3M
    CMF (20d)0.007

    Volume Metrics

    Avg Vol (20d)2.2M
    Vol Ratio0.6x
    VWMA (20d)$149.47

    Pivot Points

    R3$159.68
    R2$158.00
    R1$156.81
    Pivot Point$155.13
    S1$153.94
    S2$152.26
    S3$151.07

    Advanced Oscillators

    TSI35.80
    Ultimate Osc54.8
    KST190.64

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$729.69M$711.12M$772.06M$698.95M$720.28M$664.76M$729.37M$684.05M$691.68M$649.92M$1.37B$0
    Cost of Revenue$312.82M$323.46M$350.40M$324.35M$327.73M$289.22M$317.08M$299.23M$306.18M$294.87M$312.42M$298.22M
    Gross Profit$416.87M$387.65M$421.66M$374.60M$392.56M$375.55M$412.29M$384.82M$385.51M$355.05M$1.05B$-298,223,000
    Operating Expenses$327.55M$311.77M$309.91M$292.71M$301.80M$303.32M$293.54M$286.67M$299.78M$310.93M$977.06M$-367,451,000
    R&D$48.97M$57.89M$58.18M$50.80M$53.27M$53.60M$49.21M$49.14M$48.13M$50.36M$49.60M$53.04M
    SG&A$278.58M$253.88M$251.73M$241.91M$248.53M$249.72M$244.33M$237.52M$251.65M$260.57M$256.72M$250.25M
    Operating Income$89.32M$75.89M$111.75M$81.90M$90.76M$72.23M$118.75M$98.15M$85.72M$44.12M$77.16M$69.23M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$25.79M$25.89M$20.19M$26.21M$22.11M$19.85M$24.19M$-2,206,000$-938,000$9.57M$45.78M$18.63M
    Income Before Tax$63.53M$49.99M$91.56M$55.69M$68.65M$52.38M$94.56M$100.36M$86.66M$34.55M$31.38M$50.60M
    Income Tax Expense$10.05M$9.10M$-4,211,000$8.46M$13.43M$10.71M$6.17M$6.97M$14.06M$5.85M$-32,188,000$18.13M
    Net Income$51.82M$40.72M$98.36M$46.65M$53.95M$42.24M$94.64M$94.37M$55.36M$26.01M$78.56M$9.50M
    EBITDA$192.66M$182.08M$215.82M$185.20M$194.76M$170.75M$224.81M$207.36M$194.84M$153.65M$184.28M$179.47M
    EBIT$89.32M$75.89M$111.75M$81.90M$90.76M$72.23M$118.75M$98.15M$85.72M$44.12M$77.16M$69.23M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about RVTY

    Government Contracts

    Gov Obligations (TTM)
    $458142
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    -79.7%
    Active Awards
    17
    New Awards (TTM)
    6
    Avg Remaining Term
    2.9 mo

    Top agency: Department of Defense at 72.4% of trailing twelve month obligations across 4 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C25626P0031Department of Veterans AffairsDepartment of Veterans Affairs$53847Oct 27, 2025
    36C24226N0121Department of Veterans AffairsDepartment of Veterans Affairs$50031Oct 1, 2025
    75N94025P00545Department of Health and Human ServicesNational Institutes of Health$43073Sep 10, 2025
    W81K0225FA104Department of DefenseDefense Health Agency$42993Sep 29, 2025
    75N90025P00699Department of Health and Human ServicesNational Institutes of Health$21714Sep 9, 2025
    140D0425P0209Department of the InteriorDepartmental Offices$16135Sep 22, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    ETFs Are Net Sellers of Revvity (RVTY) on Wednesday

    ETFs were net sellers of Revvity (RVTY) shares for the second consecutive day on Wednesday, October 14, with a net outflow of $25.7 million. Although more ETFs bought shares than sold...

    Yahoo Finance•10/16/26•Somewhat-Bearish

    ETFs Are Net Sellers of Charles River (CRL) on Wednesday

    ETFs were net sellers of Charles River Laboratories International (CRL) on Wednesday, Oct. 14, with outflows totaling $21.8 million. This marks the second consecutive day of net selling for CRL...

    GuruFocus•10/16/26•Somewhat-Bearish

    ETFs Are Net Sellers of Charles River (CRL) on Wednesday

    ETFs were net sellers of Charles River Laboratories International (CRL) on Wednesday, October 14, with a net outflow of $21.8 million...

    Yahoo Finance•10/16/26•Somewhat-Bearish

    Revvity (RVTY) Gains Ahead Of Earnings, Is The Stock Too Expensive?

    Revvity (RVTY) has seen significant share price gains, up 40.45% in three months and 57.63% year-to-date, driven by investor focus on AI tools and diagnostics ahead of its Q3 2026 earnings. Despite this momentum...

    Simply Wall Street•10/16/26•Somewhat-Bearish

    Revvity (RVTY) Gains Ahead Of Earnings, Is The Stock Too Expensive?

    Revvity (RVTY) has seen significant share price gains ahead of its Q3 2026 earnings report, driven by investor interest in its AI tools and diagnostics. Despite a 40.45% 3-month return and a 57.63% YTD gain...

    Simply Wall Street•10/16/26•Neutral

    RVTY Valuation and Fair Value

    P/E
    29.0x
    Forward P/E
    24.1x
    EV/EBITDA
    25.1x
    P/FCF
    31.0x
    PEG
    0.7x
    P/B
    2.4x
    See GNG's fair value

    RVTY Profitability: Margins, ROIC and FCF

    Gross margin
    55.0%
    Operating margin
    17.1%
    Net margin
    8.2%
    ROIC
    3.1%
    ROE
    3.2%
    FCF margin
    19.2%
    FCF yield
    3.2%

    RVTY Competitors

    CompanyTicker
    Medpace Holdings IncMEDP
    Exelixis IncEXEL
    Hologic IncHOLX
    Solventum Corp.SOLV
    Zimmer Biomet Holdings IncZBH
    Ascendis Pharma ASASND
    EXACT Sciences CorporationEXAS
    Charles River LaboratoriesCRL

    Sector: Healthcare

    RVTY Analyst Ratings

    Consensus
    Hold
    Analysts
    17
    Strong Buy
    0
    Buy
    5
    Hold
    11
    Sell
    0
    Strong Sell
    1

    RVTY Bull Case vs Bear Case

    Bull case

    • RVTY converts 19.2% of revenue into free cash flow.
    • RVTY beat EPS estimates in 100.0% of its last 8 reported quarters.

    RVTY Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    7.1%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $1.30
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 12 down

    RVTY Dividend

    Forward yield
    0.2%
    Payout ratio
    5.0%
    3Y DPS growth
    0.0%
    5Y DPS growth
    0.0%
    Pay months
    Feb, May, Aug, Nov
    RVTY dividend history

    Frequently Asked Questions About RVTY

    What is RVTY's current dividend yield?

    Revvity Inc. (RVTY) has a forward dividend yield of 0.18%.

    Does RVTY pay dividends?

    Yes, Revvity Inc. pays dividends with a forward dividend yield of 0.18%.

    What is RVTY's P/E ratio?

    Revvity Inc. has a price-to-earnings (P/E) ratio of 28.99.

    What is RVTY's market cap?

    Revvity Inc. (RVTY) has a market capitalization of $16.97B with a current stock price of $155.08.

    Related stocks

    Sector: Healthcare

    All stocks starting with R

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In